Advertisement

Autoantibodies as Diagnostic Tools

  • Gunnar Houen
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1901)

Abstract

Autoimmune diseases are very diverse and include many common diseases of unknown etiology.

Diagnosis can be challenging but can be facilitated by the identification of characteristic autoantibodies (AuAbs), which are present in varying frequencies. Identification of such AuAbs requires a range of different techniques, depending on the autoantigens in question. Each individual AuAb assay is characterized by analytical sensitivity and specificity, which in turn determines clinical sensitivity and specificity in relation to diseases. Clinical sensitivities and specificities vary much, but many AuAb analyses can be of significant help in establishing correct diagnoses. It remains unsettled whether AuAbs are generally pathogenic, but it is generally agreed that autoimmune diseases are caused by a combination of genetic and environmental factors, and that early and correct diagnosis facilitates treatment.

Key words

Autoantibodies Autoantigens Autoimmune diseases Diagnostics Sensitivity Specificity ROC curve 

References

  1. 1.
    Radic M, Pattanaik D (2018) Cellular and molecular mechanisms of anti-phospholipid syndrome. Front Immunol 9:969CrossRefGoogle Scholar
  2. 2.
    Willis R, Papalardo E, Nigel Harris E (2017) Solid phase immunoassay for the detection of anticardiolipin antibodies. Methods Mol Biol 1646:185–199CrossRefGoogle Scholar
  3. 3.
    Pericleous C, Ripoll VM, Giles I, Ioannou Y (2014) Laboratory tests for the antiphospholipid syndrome. Methods Mol Biol 1134:221–235CrossRefGoogle Scholar
  4. 4.
    Conti F, Alessandri C, Spinelli FR, Capozzi A, Martinelli F, Recalchi S, Misasi R, Valesini G, Sorice M (2014) TLC immunostaining for detection of "antiphospholipid" antibodies. Methods Mol Biol 1134:95–101CrossRefGoogle Scholar
  5. 5.
    Raby A, Moffat K, Crowther M (2013) Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assays. Methods Mol Biol 992:387–405CrossRefGoogle Scholar
  6. 6.
    Gastaldi M, Waters P, Vincent A (2017) Detection of NMDAR antibodies in encephalitis. Methods Mol Biol 1677:117–126CrossRefGoogle Scholar
  7. 7.
    Byrne G, Feighery CF (2015) Celiac disease: diagnosis. Methods Mol Biol 1326:15–22CrossRefGoogle Scholar
  8. 8.
    Wyatt R, Williams AJ (2016) Islet autoantibody analysis: radioimmunoassays. Methods Mol Biol 1433:57–83CrossRefGoogle Scholar
  9. 9.
    Yu L (2016) Islet autoantibody detection by electrochemiluminescence (ECL) assay. Methods Mol Biol 1433:85–91CrossRefGoogle Scholar
  10. 10.
    Kohnert KD, Rjasanowski I, Hehmke B, Hamann J, Keilacker H, Michaelis D (1994) The detection of autoantibodies to pancreatic islet cells by immunoenzyme histochemistry. Diabetes Res 25:1–12PubMedGoogle Scholar
  11. 11.
    Sarma NJ, Tiriveedhi V, Mohanakumar T (2013) Detection of antibodies to self-antigens (K-alpha 1 tubulin, collagen I, II, IV, and V, myosin, and vimentin) by enzyme-linked immunosorbent assay (ELISA). Methods Mol Biol 1034:335–341CrossRefGoogle Scholar
  12. 12.
    Mahler M, Radice A, Sinico RA, Damoiseaux J, Seaman A, Buckmelter K, Vizjak A, Buchner C, Binder WL, Fritzler MJ, Cui Z (2012) Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study. Nephrol Dial Transplant 27:243–252CrossRefGoogle Scholar
  13. 13.
    Spadaro M, Meinl E (2016) Detection of autoantibodies against myelin oligodendrocyte glycoprotein in multiple sclerosis and related diseases. Methods Mol Biol 1304:99–104CrossRefGoogle Scholar
  14. 14.
    Hedegaard CJ, Chen N, Sellebjerg F, Sørensen PS, Leslie RG, Bendtzen K, Nielsen CH (2009) Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP. Immunology 128:e451–e461CrossRefGoogle Scholar
  15. 15.
    Remacle AG, Dolkas J, Angert M, Hullugundi SK, Chernov AV, Jones RCW 3rd, Shubayev VI, Strongin AY (2018) A sensitive and selective ELISA methodology quantifies a demyelination marker in experimental and clinical samples. J Immunol Methods 455:80–87CrossRefGoogle Scholar
  16. 16.
    Langkamp M, Hörnig SC, Hörnig JB, Kirschner M, Pridzun L, Kornhuber ME (2009) Detection of myelin autoantibodies: evaluation of an assay system for diagnosis of multiple sclerosis in differentiation from other central nervous system diseases. Clin Chem Lab Med 47:1395–1400CrossRefGoogle Scholar
  17. 17.
    Albadareen R, Gronseth G, Goeden M, Sharrock M, Lechtenberg C, Wang Y (2017) Paraneoplastic autoantibody panels: sensitivity and specificity, a retrospective cohort. Int J Neurosci 127:531–538CrossRefGoogle Scholar
  18. 18.
    Kyläniemi M, Koskinen M, Karhunen P, Rantala I, Peltola J, Haapasalo H (2004) A novel frozen brain tissue array technique: immunohistochemical detection of neuronal paraneoplastic autoantibodies. Neuropathol Appl Neurobiol 30:39–45CrossRefGoogle Scholar
  19. 19.
    Rusak E, Chobot A, Krzywicka A, Wenzlau J (2016) Anti-parietal cell antibodies–diagnostic significance. Adv Med Sci 61:175–179CrossRefGoogle Scholar
  20. 20.
    Hayter SM, Cook MC (2012) Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 11:754–765CrossRefGoogle Scholar
  21. 21.
    Wang L, Wang FS, Gershwin ME (2015) Human autoimmune diseases: a comprehensive update. J Intern Med 278:369–395CrossRefGoogle Scholar
  22. 22.
    Suurmond J, Diamond B (2015) Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J Clin Invest 125:2194–2202CrossRefGoogle Scholar
  23. 23.
    Ercolini AM, Miller SD (2009) The role of infections in autoimmune disease. Clin Exp Immunol 155:1–15CrossRefGoogle Scholar
  24. 24.
    Delogu LG, Deidda S, Delitala G, Manetti R (2011) Infectious diseases and autoimmunity. J Infect Dev Ctries 5:679–687PubMedGoogle Scholar
  25. 25.
    Ray D, Yung R (2018) Immune senescence, epigenetics and autoimmunity. Clin Immunol S1521-6616(18):30210–30219Google Scholar
  26. 26.
    Perl A (2012) Pathogenesis and spectrum of autoimmunity. Methods Mol Biol 900:1–9CrossRefGoogle Scholar
  27. 27.
    Cho JH, Feldman M (2015) Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies. Nat Med 21:730–738CrossRefGoogle Scholar
  28. 28.
    Farh KK, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, Beik S, Shoresh N, Whitton H, Ryan RJ, Shishkin AA, Hatan M, Carrasco-Alfonso MJ, Mayer D, Luckey CJ, Patsopoulos NA, De Jager PL, Kuchroo VK, Epstein CB, Daly MJ, Hafler DA, Bernstein BE (2015) Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518:337–343CrossRefGoogle Scholar
  29. 29.
    Seldin MF (2015) The genetics of human autoimmune disease: a perspective on progress in the field and future directions. J Autoimmun 64:1–12CrossRefGoogle Scholar
  30. 30.
    Shoenfeld Y, Tincani A, Gershwin E (2012) Gender, sex hormones, pregnancy and autoimmunity. J Autoimmunity 38:71–291CrossRefGoogle Scholar
  31. 31.
    Shoenfeld Y, Tincani A, Gershwin E (2012) Gender, sex hormones, pregnancy and autoimmunity. Autoimmun Rev 11:377–554CrossRefGoogle Scholar
  32. 32.
    Shoenfeld Y, Youinou P, Gershwin ME (2010) The environment, geoepidemiology and autoimmune diseases. J Autoimmunity 34:163–338CrossRefGoogle Scholar
  33. 33.
    Shoenfeld Y, Youinou P, Gershwin ME (2010) The environment, geoepidemiology and autoimmune diseases. Autoimmun Rev 9:247–405CrossRefGoogle Scholar
  34. 34.
    Shoenfeld Y, Cervera R, Gershwin ME (eds) (2008) Diagnostic criteria in autoimmune diseases. Humana Press, Totowa, NJGoogle Scholar
  35. 35.
    Mahler M, Parker T, Peebles CL, Andrade LE, Swart A, Carbone Y, Ferguson DJ, Villalta D, Bizzaro N, Hanly JG, Fritzler MJ (2012) Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases. J Rheumatol 39:2104–2110CrossRefGoogle Scholar
  36. 36.
    Seelig CA, Bauer O, Seelig HP (2016) Autoantibodies against DFS70/LEDGF–exclusion markers for systemic autoimmune rheumatic diseases (SARD). Clin Lab 62(4):499–517PubMedGoogle Scholar
  37. 37.
    Ma WT, Chang C, Gershwin ME, Lian ZX (2017) Development of autoantibodies precedes clinical manifestations of autoimmune diseases: a comprehensive review. J Autoimmun 83:95–112CrossRefGoogle Scholar
  38. 38.
    Derksen VFAM, Huizinga TWJ, van der Woude D (2017) The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin Immunopathol 39:437–446CrossRefGoogle Scholar
  39. 39.
    Kumar A, de Leiva A (2017) Latent autoimmune diabetes in adults (LADA) in Asian and European populations. Diabetes Metab Res Rev 33.  https://doi.org/10.1002/dmrr.2890
  40. 40.
    Aggarwal A (2014) Role of autoantibody testing. Best Pract Res Clin Rheumatol 28:907–920CrossRefGoogle Scholar
  41. 41.
    Hu ZD, Deng AM (2014) Autoantibodies in pre-clinical autoimmune disease. Clin Chim Acta 437:14–18CrossRefGoogle Scholar
  42. 42.
    Wild D (ed) (2013) The immunoassay handbook. Elsevier, OxfordGoogle Scholar
  43. 43.
    Johnstone AP, Turner MW (eds) (2002) Immunochemistry–a practical approach. Oxford University Press, New YorkGoogle Scholar
  44. 44.
    Harlow E, Lane D (eds) (1988) Antibodies–a laboratory manual. Cold Spring Harbor laboratory Press, Cold Spring Harbor, NYGoogle Scholar
  45. 45.
    Larsson L-I (1988) Immunocytochemistry: theory and practice. CRC Press, Boca Raton, FLGoogle Scholar
  46. 46.
    Herman RA, Scherer PN, Shan G (2008) Evaluation of logistic and polynomial models for fitting sandwich-ELISA calibration curves. J Immunol Methods 339:245–258CrossRefGoogle Scholar
  47. 47.
    Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56:1129–1135CrossRefGoogle Scholar
  48. 48.
    Greiner M, Pfeiffer D, Smith RD (2000) Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 45:23–41CrossRefGoogle Scholar
  49. 49.
    Carter JV, Pan J, Rai SN, Galandiuk S (2016) ROC-ing along: evaluation and interpretation of receiver operating characteristic curves. Surgery 159:1638–1645CrossRefGoogle Scholar
  50. 50.
    Trier N, Izarzugaza J, Chailyan A, Marcatili P, Houen G (2018) Human MHC-II with shared epitope motifs are optimal epstein-barr virus glycoprotein 42 ligands-relation to rheumatoid arthritis. Int J Mol Sci 19:E317.  https://doi.org/10.3390/ijms19010317CrossRefPubMedGoogle Scholar
  51. 51.
    Bodis G, Toth V, Schwarting A (2018) Role of human leukocyte antigens (HLA) in autoimmune diseases. Methods Mol Biol 1802:11–29CrossRefGoogle Scholar
  52. 52.
    Karopka T, Fluck J, Mevissen HT, Glass A (2006) The autoimmune disease database: a dynamically compiled literature-derived database. BMC Bioinformatics 7:325CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of AutoimmunologyStatens Serum InstitutCopenhagenDenmark
  2. 2.Department of Biochemistry and Molecular BiologyUniversity of Southern DenmarkOdenseDenmark

Personalised recommendations